Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2012

Summary

Companys clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H2, 2011 provides data on the Hepatocellular Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatocellular Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatocellular Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 2
List of Tables 5
List of Figures 7
Introduction 8
Hepatocellular Carcinoma 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Hepatocellular Carcinoma 25
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Hepatocellular Carcinoma Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Bayer AG 37
Clinical Trial Overview of Bayer AG 37
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Sanofi 41
Clinical Trial Overview of Sanofi 41
Eli Lilly and Company 42
Clinical Trial Overview of Eli Lilly and Company 42
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
Taiho Pharmaceutical Co., Ltd. 44
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 44
Jennerex Biotherapeutics, Inc. 45
Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 45
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Eisai Inc. 47
Clinical Trial Overview of Eisai Inc. 47
GlaxoSmithKline plc 48
Clinical Trial Overview of GlaxoSmithKline plc 48
Abbott Laboratories 49
Clinical Trial Overview of Abbott Laboratories 49
Chugai Pharmaceutical Co., Ltd. 50
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd. 50
ArQule, Inc. 51
Clinical Trial Overview of ArQule, Inc. 51
Celsion Corporation 52
Clinical Trial Overview of Celsion Corporation 52
F. Hoffmann-La Roche Ltd. 53
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 53
Boehringer Ingelheim GmbH 54
Clinical Trial Overview of Boehringer Ingelheim GmbH 54
Adherex Technologies Inc. 55
Clinical Trial Overview of Adherex Technologies Inc. 55
Amgen Inc. 56
Clinical Trial Overview of Amgen Inc. 56
Otsuka Pharmaceutical Co., Ltd. 57
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 57
Clinical Trial Overview of Top Universities / Institutes / Hospitals 58
Eastern Hepatobiliary Surgery Hospital 58
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 58
Sun Yat-sen University 60
Clinical Trial Overview of Sun Yat-sen University 60
FUDAN University 62
Clinical Trial Overview of FUDAN University 62
Seoul National University Hospital 63
Clinical Trial Overview of Seoul National University Hospital 63
Kaohsiung Medical University Chung-Ho Memorial Hospital 64
Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital 64
Assistance Publique - Hopitaux de Paris 65
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 65
University of Milan 66
Clinical Trial Overview of University of Milan 66
Massachusetts General Hospital 67
Clinical Trial Overview of Massachusetts General Hospital 67
Stanford University 68
Clinical Trial Overview of Stanford University 68
Kyoto University 69
Clinical Trial Overview of Kyoto University 69
Niigata Hepatocellular Carcinoma Therapy Study Group 70
Clinical Trial Overview of Niigata Hepatocellular Carcinoma Therapy Study Group 70
University Health Network 71
Clinical Trial Overview of University Health Network 71
University of Pittsburgh 72
Clinical Trial Overview of University of Pittsburgh 72
Chinese University of Hong Kong 73
Clinical Trial Overview of Chinese University of Hong Kong 73
The University of Tokyo Hospital 74
Clinical Trial Overview of The University of Tokyo Hospital 74
Kanazawa Medical University 75
Clinical Trial Overview of Kanazawa Medical University 75
Yokohama City University Medical Center 76
Clinical Trial Overview of Yokohama City University Medical Center 76
The University of Texas M. D. Anderson Cancer Center 77
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 77
All India Institute of Medical Sciences 78
Clinical Trial Overview of All India Institute of Medical Sciences 78
Sidney Kimmel Comprehensive Cancer Center 79
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 79
Five Key Clinical Profiles 80
Appendix 118
Abbreviations 118
Definitions 118
Research Methodology 120
Secondary Research 120
About Company 121
Contact Us 121
Disclaimer 121
Source 122

List of Tables

Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Hepatocellular Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Hepatocellular Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Hepatocellular Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Hepatocellular Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15
Hepatocellular Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
Hepatocellular Carcinoma Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Hepatocellular Carcinoma Therapeutics Clinical Trials, G7 Countries, 2012* 18
Hepatocellular Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Hepatocellular Carcinoma Therapeutics Clinical Trials, E7 Countries, 2012* 20
Hepatocellular Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Hepatocellular Carcinoma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Hepatocellular Carcinoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Hepatocellular Carcinoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 37
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 39
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 40
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 41
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 42
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 43
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 44
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012* 45
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 46
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 47
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 48
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 49
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chugai Pharmaceutical Co., Ltd., 2012* 50
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012* 51
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012* 52
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 53
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 54
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Adherex Technologies Inc., 2012* 55
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 56
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012* 57
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Hepatobiliary Surgery Hospital, 2012* 58
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 60
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 62
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 63
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Medical University Chung-Ho Memorial Hospital, 2012* 64
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 65
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012* 66
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 67
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 68
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 69
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Niigata Hepatocellular Carcinoma Therapy Study Group, 2012* 70
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 71
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 72
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012* 73
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2012* 74
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa Medical University, 2012* 75
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University Medical Center, 2012* 76
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 77
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2012* 78
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 79

List of Figures

Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Hepatocellular Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Hepatocellular Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Hepatocellular Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Hepatocellular Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15
Hepatocellular Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
Hepatocellular Carcinoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Hepatocellular Carcinoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Hepatocellular Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Hepatocellular Carcinoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Hepatocellular Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
Company Methodology 120